TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors ; volume:73 ; number:9 ; day:2 ; month:7 ; year:2024 ; pages:1-13 ; date:9.2024
Cancer immunology immunotherapy ; 73, Heft 9 (2.7.2024), 1-13, 9.2024

Creator: Pearson, Joshua R. D.
Puig-Saenz, Carles
Thomas, Jubini E.
Hardowar, Lydia D.
Ahmad, Murrium
Wainwright, Louise C.
McVicar, Adam M.
Brentville, Victoria A.
Tinsley, Chris J.
Pockley, Alan Graham
Durrant, Lindy G.
McArdle, Stephanie E. B.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00262-024-03770-x

URN: urn:nbn:de:101:1-2410310827143.829750240113

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pearson, Joshua R. D.
Puig-Saenz, Carles
Thomas, Jubini E.
Hardowar, Lydia D.
Ahmad, Murrium
Wainwright, Louise C.
McVicar, Adam M.
Brentville, Victoria A.
Tinsley, Chris J.
Pockley, Alan Graham
Durrant, Lindy G.
McArdle, Stephanie E. B.
SpringerLink (Online service)

Other Objects (12)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection

Strategies for sensitizing tumors to Anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Related objects

Reset password